Supernus Pharmaceuticals Inc (SUPN)
US$ 30.94-4.59%
Price Chart
Key Statistics
Market Cap
$ 1.81B
P/E Ratio
24.58
Revenue (TTM)
$ 661.82M
Volume
1.07M
52W High
$ 40.28
52W Low
$ 25.53
Dividend Yield
0.00%
Beta
0.90
Technicals
50-Day MA
32.0246
200-Day MA
33.9982
52 Week High
40.28
52 Week Low
25.53
About SUPN
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.
Employees
674
Headquarters
Rockville, MD
CEO
Mr. Jack A. Khattar M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg